Case Studies
With more than 2,200 attorneys and professionals practicing in over 250 areas of law, Holland & Knight can provide you with comprehensive legal representation.
Healthcare & Life Sciences
Clear All
Results
Showing of
Protecting U.S. Trademarks Abroad
U.S. companies facing trademark challenges in international markets have a trailblazing advocate in Holland & Knight. Our Intellectual Property team established the first industry group to compile a "report card" on countries that fail to adequately protect trademark rights – and the Office of the United States Trade Representative (USTR) is listening.
Protecting Patent Clients in Alice's Wonderland
The U.S. Supreme Court ruled in Alice Corp. v. CLS Bank that laws of nature, natural phenomena and abstract ideas are not patentable. Using Alice, Holland & Knight's Intellectual Property Group has won several patent-infringement cases for clients. The attorneys challenged the patents at the outset, saving clients from costly discovery and prolonged litigation.
Increasing Market Share Through Strategic Acquisitions
When pharmaceutical innovator Sunovion sought to expand the number of products it offers for treating chronic obstructive pulmonary disease (COPD), it relied on experienced counsel from Holland & Knight in its $430 million acquisition of Elevation Pharmaceuticals, a privately held biopharmaceutical company specializing in aerosol therapies for individuals with respiratory diseases.
Advocating for Drug Regulation Reform
Facing unintended consequences from FDA policies on unapproved drugs that could have removed common medical gases from the market, the Compressed Gas Association turned to Holland & Knight's Public Policy & Regulation Group to achieve a legislative solution. The historic reforms that resulted helped to avoid a potentially catastrophic result for the industry.
Protecting Venture Capital Client from Bankruptcy Fallout
Holland & Knight's financial services, FCC, bankruptcy, CFIUS and industrial security attorneys advised a life sciences and technology venture lending partner in connection with a senior secured term loan made to a space communications company whose principal asset was a space station (satellite) spectrum license granted by the FCC.
Improving Biosimilars and Patient Care
Holland & Knight's Public Policy & Regulation Group secured a major victory for healthcare client Biosimilars Forum when the Centers for Medicare & Medicaid Services said it will begin issuing unique HCPCS codes to each individual biosimilar product.
Funding the Battle Against Ebola
When a biosciences startup sought federal funding to combat Ebola, our Healthcare & Life Sciences Team and Venture Capital & Emerging Companies Team provided key assistance in the grant application, federal relations and corporate formation. In a matter of months, the firm helped the company win a major federal grant for its promising approach to preventing surface contamination.
